Literature DB >> 17365774

Smoking cessation patterns in methadone-maintained smokers.

Michael D Stein1, Bradley J Anderson, Raymond Niaura.   

Abstract

To determine predictors of smoking cessation duration in a randomized clinical trial, we assigned participants to nicotine patch (8-12 weeks) plus either (a) a baseline tailored brief motivational intervention, a quit date behavioral skills counseling session, and a relapse prevention follow-up session, or (b) brief advice using the National Cancer Institute's 4A's model. A total of 383 smokers from five methadone maintenance treatment centers in Rhode Island were enrolled, of whom 312 (82%) completed 6-month follow-up assessments. The primary outcome was longest period of self-reported abstinence during follow-up. Participants were on average 40.5 years of age; 51.9% were male, and 77.6% were White. In multivariate analysis controlling for demographics, nicotine dependence, depressive symptoms, and smoking-related symptoms, we found longer periods of abstinence in persons reporting at least one 24-hr quit attempt in the year prior to baseline (OR = 1.97, p = .003), in those anticipating success in cessation (OR = 1.33, p = .024), and in those with a greater percentage of nicotine patch use days (OR = 2.78, p<.001). Past quit attempts, self-efficacy, and constant nicotine replacement were associated with duration of abstinence among methadone-maintained smokers. Attention to these domains in future intervention studies may improve treatment success.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17365774     DOI: 10.1080/14622200701188885

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  14 in total

1.  Early quit days among methadone-maintained smokers in a smoking cessation trial.

Authors:  Marcel A de Dios; Bradley J Anderson; Celeste M Caviness; Michael D Stein
Journal:  Nicotine Tob Res       Date:  2014-06-20       Impact factor: 4.244

Review 2.  Are Pharmacotherapies Ineffective in Opioid-Dependent Smokers? Reflections on the Scientific Literature and Future Directions.

Authors:  Mollie E Miller; Stacey C Sigmon
Journal:  Nicotine Tob Res       Date:  2015-08       Impact factor: 4.244

Review 3.  Achieving Smoking Cessation Among Persons with Opioid Use Disorder.

Authors:  Cynthia Vlad; Julia H Arnsten; Shadi Nahvi
Journal:  CNS Drugs       Date:  2020-04       Impact factor: 5.749

4.  An Open Trial of Electronic Cigarettes for Smoking Cessation Among Methadone-Maintained Smokers.

Authors:  Michael D Stein; Celeste Caviness; Kristin Grimone; Daniel Audet; Bradley J Anderson; Genie L Bailey
Journal:  Nicotine Tob Res       Date:  2015-12-28       Impact factor: 4.244

5.  Varenicline for smoking cessation among methadone-maintained smokers: a randomized clinical trial.

Authors:  M D Stein; C M Caviness; M E Kurth; D Audet; J Olson; B J Anderson
Journal:  Drug Alcohol Depend       Date:  2013-08-14       Impact factor: 4.492

6.  Determining Smoking Cessation Related Information, Motivation, and Behavioral Skills among Opiate Dependent Smokers in Methadone Treatment.

Authors:  Nina A Cooperman; Kimber P Richter; Steven L Bernstein; Marc L Steinberg; Jill M Williams
Journal:  Subst Use Misuse       Date:  2015-01-05       Impact factor: 2.164

7.  Low incidence of adverse events following varenicline initiation among opioid dependent smokers with comorbid psychiatric illness.

Authors:  Shadi Nahvi; Bryan Wu; Kimber P Richter; Steven L Bernstein; Julia H Arnsten
Journal:  Drug Alcohol Depend       Date:  2013-01-17       Impact factor: 4.492

8.  Tobacco Use among Recovery Home Residents: Vapers Less Confident to Quit.

Authors:  Meme Wang-Schweig; Leonard A Jason; Ed Stevens; Jessica Chaparro
Journal:  Am J Health Behav       Date:  2019-11-01

9.  Feasibility of promoting smoking cessation among methadone users using multimedia computer-assisted education.

Authors:  Joseph Finkelstein; Oleg Lapshin; Eunme Cha
Journal:  J Med Internet Res       Date:  2008-11-03       Impact factor: 5.428

10.  Effect of varenicline directly observed therapy versus varenicline self-administered therapy on varenicline adherence and smoking cessation in methadone-maintained smokers: a randomized controlled trial.

Authors:  Shadi Nahvi; Tangeria R Adams; Yuming Ning; Chenshu Zhang; Julia H Arnsten
Journal:  Addiction       Date:  2020-10-13       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.